Patents by Inventor Travis E. HELM

Travis E. HELM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
    Publication number: 20220409575
    Abstract: The subject matter disclosed herein relates to novel doses and dosage forms of rofecoxib having a therapeutic benefit.
    Type: Application
    Filed: June 30, 2022
    Publication date: December 29, 2022
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Raymond D. Skwierczynski, Travis E. Helm
  • TREATMENT OF VIRAL HEMORRHAGIC FEVERS WITH ETORICOXIB
    Publication number: 20220273609
    Abstract: The subject matter disclosed herein relates to methods of treating viral hemorrhagic fever in a subject in need thereof by administering a pharmaceutically acceptable dose of etoricoxib. In some embodiments, the etoricoxib is administered in combination with other suitable pharmaceutical compositions.
    Type: Application
    Filed: October 1, 2021
    Publication date: September 1, 2022
    Inventors: Bradford C. SIPPY, Travis E. HELM
  • NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
    Publication number: 20220047542
    Abstract: The subject matter disclosed herein relates to novel doses and dosage forms of rofecoxib having a therapeutic benefit.
    Type: Application
    Filed: October 28, 2021
    Publication date: February 17, 2022
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Raymond D. Skwierczynski, Travis E. Helm
  • NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
    Publication number: 20210169845
    Abstract: The subject matter disclosed herein relates to novel doses and dosage forms of rofecoxib having a therapeutic benefit.
    Type: Application
    Filed: February 23, 2021
    Publication date: June 10, 2021
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Raymond D. Skwierczynski, Travis E. Helm
  • NOVEL DOSAGE FORMS OF ROFECOXIB AND RELATED METHODS
    Publication number: 20210137878
    Abstract: The subject matter disclosed herein relates to novel doses and dosage forms of rofecoxib having a therapeutic benefit.
    Type: Application
    Filed: December 18, 2020
    Publication date: May 13, 2021
    Applicant: Tremeau Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Raymond D. Skwierczynski, Travis E. Helm
  • Dosage forms of rofecoxib and related methods
    Patent number: 10945992
    Abstract: The subject matter disclosed herein relates to novel doses and dosage forms of rofecoxib having a therapeutic benefit.
    Type: Grant
    Filed: May 5, 2020
    Date of Patent: March 16, 2021
    Assignee: Tremeau Pharmaceuticals, Inc.
    Inventors: Bradford C. Sippy, Raymond D. Skwierczynski, Travis E. Helm
  • TREATMENT OF VIRAL HEMORRHAGIC FEVERS WITH COX-2 SELECTIVE NON-STEROIDAL ANTI-INFLAMMATORY DRUGS
    Publication number: 20200323813
    Abstract: The present disclosure relates to a method of treating symptoms of fever, pain, and inflammation in patients infected with a Viral Hemorrhagic Fever, the method comprising administering a COX-2 selective Non-Steroidal Anti-Inflammatory Drug (NSAID) at a sufficient dose to reduce both the symptoms and viral level of the infection, and matching the dose of a COX-2 selective NSAID to the time course of the Viral Hemorrhagic Fever to provide maximum anti-pyretic effect during the febrile phase of the infection and retain a lower maintenance dose during the remainder of the infection.
    Type: Application
    Filed: April 8, 2020
    Publication date: October 15, 2020
    Inventors: Bradford C. SIPPY, Travis E. HELM
  • TREATMENT OF VIRAL HEMORRHAGIC FEVERS WITH ETORICOXIB
    Publication number: 20200323830
    Abstract: The subject matter disclosed herein relates to methods of treating viral hemorrhagic fever in a subject in need thereof by administering a pharmaceutically acceptable dose of etoricoxib. In some embodiments, the etoricoxib is administered in combination with other suitable pharmaceutical compositions.
    Type: Application
    Filed: April 8, 2020
    Publication date: October 15, 2020
    Inventors: Bradford C. SIPPY, Travis E. HELM